Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,435 | -5,976 | -2,720 | -20,983 | -15,651 |
| Depreciation Amortization | -145 | -99 | -44 | -72 | -35 |
| Accounts payable and accrued liabilities | -358 | -192 | -210 | 352 | 558 |
| Other Working Capital | -2,624 | -1,460 | -1,512 | 1,636 | 1,064 |
| Other Operating Activity | 1,715 | 1,240 | 740 | 2,364 | 1,660 |
| Operating Cash Flow | $-9,846 | $-6,486 | $-3,746 | $-16,702 | $-12,405 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -20,699 | -16,729 | -13,210 | -33,056 | -24,747 |
| Sale Of Investment | 27,039 | 16,600 | 12,300 | 36,182 | 29,682 |
| Other Investing Activity | 7 | 7 | 7 | 0 | 0 |
| Investing Cash Flow | $6,347 | $-122 | $-903 | $3,126 | $4,935 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | N/A | N/A |
| Common Stock Issued | 91 | N/A | 0 | 11,226 | 11,180 |
| Financing Cash Flow | $10,091 | $10,000 | $10,000 | $11,226 | $11,180 |
| Beginning Cash Position | 3,211 | 3,211 | 3,211 | 5,561 | 5,561 |
| End Cash Position | 9,803 | 6,602 | 8,561 | 3,211 | 9,271 |
| Net Cash Flow | $6,592 | $3,391 | $5,351 | $-2,350 | $3,710 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,846 | -6,486 | -3,746 | -16,702 | -12,405 |
| Free Cash Flow | -9,846 | -6,486 | -3,746 | -16,702 | -12,405 |